Navigation on this site is not optimized for your browser

Please use a recent version of Google Chrome, Mozilla Firefox, Safari or Microsoft Edge to get the most out of the experience.

Find a modern browser

White paper - Microgravity for biotech & pharma

All levels of biological organisation, cells, tissues, organs, organisms, are affected by microgravity often in novel and useful ways, sometimes in ways that allow medical, biotech and other problems on Earth to be better addressed. The benefits of microgravity allow to manufacture medicines, materials and living tissue that cannot be done in Earth’s 1g gravity environment.

Microgravity provides very strong value features for research and manufacturing in the biosciences area, just to list some:

Enhanced Cell Culture: Cell culture is the basis of many experiments in terrestrial based biology and biotechnology research. It is also heavily utilised by the pharmaceutical and healthcare industries. Cells cultured in a lab on Earth form a flat carpet on the bottom of the petri dish, unless a matrix or scaffolding is added to force the cells to form a 3D structure similar to those in the human body. When cells are cultured in microgravity, they form 3D structures like those in the human body and cell-cell communication resembles that in the human body, creating an environment excellent for testing drug efficacy and drug safety. Stem cells have been shown to have more “stemness” when grown in microgravity and microgravity accelerates the growth rate of cells.

Microgravity Molecular Crystal Growth: The process of crystal growth, known as crystallisation, benefits from microgravity due to the lack of sedimentation and convection which results in larger, nearly defect free crystals being grown on the ISS with associated unique characteristics and behaviours.

Space induces changes resulting in bone loss, immune dysfunction, cardiovascular deconditioning, loss of skeletal muscle. These changes mimic the onset of health-related outcomes associated with ageing and debilitating chronic human diseases on Earth, hence the LEO environment can be utilised for modelling human diseases. Also from this perspective the microgravity environment in Low Earth Orbit creates a unique testing environment for drug development and drug testing.

Bacteria and yeasts produce different secondary metabolites when grown in low shear suspended conditions, as in space, producing novel flavours, pigments, antioxidants, enzymes, etc.

All aspects which make the microgravity environment ideal for research and manufacturing in the Biotech & Pharma sectors.

If you want to read the full white paper on the topic, please contact us below with message “White paper – Microgravity for Biotech & Pharma”.

enables formation of 3D cell cultures and grows larger crystals

This website uses cookies

We use cookies and similar technologies to adjust your preferences, analyse traffic and measure the effectiveness of campaigns. You consent to the use of our cookies by continuing to browse this website.
  • Analytics

    Google Tag Manager

    Cookie from Google Tag Manager allows us to set up and manage the sending of data to the different analysis services listed below (e.g. Google Analytics)


    Cookie from Google Analytics allows us to anonymously count visits, the sources of these visits as well as the actions taken on the site by visitors.

    Storage time 12 months

  • Essentials


    Cookie that remembers the user's choice of cookie preferences


    The server saves the language chosen by the user to display the correct version of the pages

    Storage time 12 months

This website uses cookies

We use cookies and similar techonologies to adjust your preferences, analyze traffic and measure the effectiveness of campaigns. You consent to the use of our cookies by continuing to browse this website.